NasdaqGM - Delayed Quote USD

First Trust Nasdaq Pharmaceuticals ETF (FTXH)

25.91 +0.06 (+0.25%)
At close: April 26 at 4:00 PM EDT

Top 10 Holdings (54.48% of Total Assets)

SymbolCompany% Assets
BMY
Bristol-Myers Squibb Company 7.55%
PFE
Pfizer Inc. 7.39%
MRK
Merck & Co., Inc. 7.34%
ABBV
AbbVie Inc. 7.31%
JNJ
Johnson & Johnson 6.93%
AMGN
Amgen Inc. 3.67%
LLY
Eli Lilly and Company 3.65%
GILD
Gilead Sciences, Inc. 3.59%
CAH
Cardinal Health, Inc. 3.53%
REGN
Regeneron Pharmaceuticals, Inc. 3.52%

Sector Weightings

SectorFTXH
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Stocks 99.94%
Bonds 0.00%

Equity Holdings

Price/Earnings 0.04
Price/Book 0.29
Price/Sales 0.56
Price/Cashflow 0.07
Median Market Cap --
3 Year Earnings Growth --

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

ETF Summary

The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking. It is non-diversified.

ETF Overview

Category Health
Fund Family First Trust Advisors L.P.
Net Assets 21M
YTD Daily Total Return -2.40%
Yield 1.36%
Legal Type Exchange Traded Fund

Related Tickers